These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 1908085)

  • 1. Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis.
    Heinzel FP; Sadick MD; Mutha SS; Locksley RM
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7011-5. PubMed ID: 1908085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.
    Heinzel FP; Sadick MD; Holaday BJ; Coffman RL; Locksley RM
    J Exp Med; 1989 Jan; 169(1):59-72. PubMed ID: 2521244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the precursor frequencies of IL-4 and IFN-gamma secreting CD4+ cells correlate with resolution of lesions in murine cutaneous leishmaniasis.
    Morris L; Troutt AB; Handman E; Kelso A
    J Immunol; 1992 Oct; 149(8):2715-21. PubMed ID: 1357029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis.
    Scott P
    J Immunol; 1991 Nov; 147(9):3149-55. PubMed ID: 1833466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of cytokine patterns produced by individual CD4+ lymph node cells during experimental murine leishmaniasis in resistant and susceptible mice.
    Sommer F; Meixner M; Mannherz M; Ogilvie AL; Röllinghoff M; Lohoff M
    Int Immunol; 1998 Dec; 10(12):1853-61. PubMed ID: 9885906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-12 but not interferon-gamma production correlates with induction of T helper type-1 phenotype in murine candidiasis.
    Romani L; Mencacci A; Tonnetti L; Spaccapelo R; Cenci E; Wolf S; Puccetti P; Bistoni F
    Eur J Immunol; 1994 Apr; 24(4):909-15. PubMed ID: 7908634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
    Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
    J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant interleukin 12 cures mice infected with Leishmania major.
    Heinzel FP; Schoenhaut DS; Rerko RM; Rosser LE; Gately MK
    J Exp Med; 1993 May; 177(5):1505-9. PubMed ID: 8097524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection.
    Reiner SL; Zheng S; Wang ZE; Stowring L; Locksley RM
    J Exp Med; 1994 Feb; 179(2):447-56. PubMed ID: 7905017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming.
    Seder RA; Gazzinelli R; Sher A; Paul WE
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10188-92. PubMed ID: 7901851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice.
    Lehmann J; Enssle KH; Lehmann I; Emmendörfer A; Lohmann-Matthes ML
    J Interferon Cytokine Res; 2000 Jan; 20(1):63-77. PubMed ID: 10670653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to murine cutaneous leishmaniasis is mediated by TH1 cells, but disease-promoting CD4+ cells are different from TH2 cells.
    Moll H; Röllinghoff M
    Eur J Immunol; 1990 Sep; 20(9):2067-74. PubMed ID: 1976523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-2 is necessary for the progression of leishmaniasis in susceptible murine hosts.
    Heinzel FP; Rerko RM; Hatam F; Locksley RM
    J Immunol; 1993 May; 150(9):3924-31. PubMed ID: 8473741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis.
    Kaye PM; Curry AJ; Blackwell JM
    J Immunol; 1991 Apr; 146(8):2763-70. PubMed ID: 1901883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The early IL-4 response to Leishmania major and the resulting Th2 cell maturation steering progressive disease in BALB/c mice are subject to the control of regulatory CD4+CD25+ T cells.
    Aseffa A; Gumy A; Launois P; MacDonald HR; Louis JA; Tacchini-Cottier F
    J Immunol; 2002 Sep; 169(6):3232-41. PubMed ID: 12218142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental murine Trypanosoma congolense infections. II. Role of splenic adherent CD3+Thy1.2+ TCR-alpha beta- gamma delta- CD4+8- and CD3+Thy1.2+ TCR-alpha beta- gamma delta- CD4-8- cells in the production of IL-4, IL-10, and IFN-gamma and in trypanosome-elicited immunosuppression.
    Uzonna JE; Kaushik RS; Zhang Y; Gordon JR; Tabel H
    J Immunol; 1998 Dec; 161(11):6189-97. PubMed ID: 9834105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (Il) 4/Il-10-producing (Th2) negative regulatory CD4+ T cells.
    Xu H; DiIulio NA; Fairchild RL
    J Exp Med; 1996 Mar; 183(3):1001-12. PubMed ID: 8642241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ and/or gammadelta+ T cells in the liver spontaneously produce IL-4 in vitro during the early phase of Leishmania major infection in susceptible BALB/c mice.
    Yamashita T; Miyata H; Miyaji C; Watanabe H; Abo T; Kobayakawa T; Kaneko A; Sendo F
    Acta Trop; 1999 Jul; 73(2):109-19. PubMed ID: 10465051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism.
    Sadick MD; Heinzel FP; Holaday BJ; Pu RT; Dawkins RS; Locksley RM
    J Exp Med; 1990 Jan; 171(1):115-27. PubMed ID: 2104918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine cutaneous leishmaniasis: susceptibility correlates with differential expansion of helper T-cell subsets.
    Locksley RM; Heinzel FP; Sadick MD; Holaday BJ; Gardner KD
    Ann Inst Pasteur Immunol; 1987; 138(5):744-9. PubMed ID: 2964247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.